Clinical Trial Update: A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating omega-3 fatty acids as an augmentation to antidepressant treatment for major depressive disorder; the study status is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: The University of New South Wales | Conditions: Major Depression | Phase 2 | Status: UNKNOWN